References
- WHO. Access to medicines: Making market forces serve the poor. 2017. http://www.who.int/publications/10-year-review/en/. Accessed 15 Dec 2021.
- Ozawa S, Shankar R, Leopold C, Orubu S. Access to medicines through health systems in low- and middle-income countries. Health Policy Plan. 2019;34(Suppl 3):iii1–iii3.
- WHO. World health statistics 2019: monitoring health for the SDGs, sustainable development goals. 2019. https://www.who.int/publications/i/item/world-health-statistics-2019-monitoring-health-for-the-sdgs-sustainable-development-goals. Accessed 15 Dec 2021.
- Lenssen G, Arenas D, Lacy P, Pickard S, Sturchio JL. Business engagement in public programs: the pharmaceutical industry’s contribution to public health and the millennium development goals. Corp Gov. 2008;8:482–489.
- Lee M, Choi M. The determinants of research and development investment in the pharmaceutical industry: focus on financial structures. Osong Public Health Res Perspect. 2015;6:302–309.
- Alt S, Helmstädter A. Market entry, power, pharmacokinetics: what makes a successful drug innovation? Drug Discov Today. 2018;23:208–212.
- Grevsen JV, Kirkegaard H, Kruse E, Kruse PR. Early achievements of the Danish pharmaceutical industry-8. Lundbeck Theriaca. 2016;43:9–61
- Liu C, Constantinides PP, Li Y. Research and development in drug innovation: reflections from the 2013 bioeconomy conference in China, lessons learned and future perspectives. Acta Pharm Sin B. 2014;4:112–119.
- Basavaraj S, Betageri GV. Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges. Acta Pharm Sin B. 2014;4:3–17.
- Forster SP, Stegmaier J, Spycher R, et al. Virtual pharmaceutical companies: collaborating flexibly in pharmaceutical development. Drug Discov Today. 2014;19:348–355.
- Congressional Research Service. Pharmaceutical Research and Development: A Description and Analysis of the Process. Institution; 2001. https://www.everycrsreport.com/reports/RL30913.html. Accessed 05 Feb 2021.
- Nyigo VA, Malebo HM. Drug discovery and developments in developing countries: bottlenecks and way forward. Tanzan Health Res Bull. 2005;7:154–158.
- Pheage T. Dying from lack of medicines: Encouraging local production, right policies the way out. 2017. https://www.un.org/africarenewal/magazine/december-2016-march-2017/dying-lack-medicines. Accessed 11 Dec 2021.
- WHO. Local Production for Access to Medical Products: Developing a Framework to Improve Public Health. 2011. https://www.who.int/phi/publications/Local_Production_Policy_Framework.pdf. Accessed 10 Dec 2021.
- Ministry of Health and Ministry of Industry. National strategy and plan of action for pharmaceutical manufacturing development in Ethiopia (2015–2025): Developing the pharmaceutical industry and improving access. 2015. https://www.who.int/phi/publications/Ethiopia_strategy_local_poduction.pdf?ua=1. Accessed 10 Dec 2021.
- Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.
- Temple B, Young A. Qualitative research and translation dilemmas. Qual Res. 2004;4:161–178.
- Huang R. RQDA: R-based qualitative data analysis. R Package Version 3.3.2. 2016. http://rqda.r-forge.r-project.org/. Accessed 07 Feb 2017.
- Woldegiyorgis AA. The vicious circle of quality in Ethiopian higher education. Int Higher Educ. 2017;90:18–19.
- Alam M, Yigzaw GS. Causes and impacts of foreign currency reserve crises in Ethiopia Üniversitepark Bülten. 2020;9:15–27.